Effects of synthetic biomacromolecule addition on the flow behavior of concentrated mesenchymal cell suspensions.

In the fields of tissue engineering and regenerative medicine, many researchers and companies alike are investigating the utility of concentrated mesenchymal stem cell suspensions as therapeutic injectables, with the hope of regenerating the damaged tissue site. These cells are seldom used alone, being instead combined with synthetic biomacromolecules, such as branched poly(ethylene glycol) (PEG) polymers, in order to form cross-linked hydrogels postinjection. In this article, we present the results of a detailed experimental and analytical investigation into the impacts of a range of eight-arm PEG polymers, each presenting functional end groups, on the rheological properties of concentrated living cells of mesenchymal origin. Using two-photon confocal microscopy, we confirmed that the aggregates formed by the cells are fractal structures, the dimension of which changed with PEG polymer type addition. From these results and the observed substantial variation in rheological footprint with increasing volume fraction and different PEG polymer type, we propose a number of mechanisms driving such structural changes. Lastly, we derived a modified Krieger-Dougherty model to produce a master curve for the relative viscosity as a function of volume fraction over the range of conditions investigated (including shear stress and PEG polymer type), from which we extract the adhesion force between individual cells within these concentrated suspensions. The outcomes of this study provide new insights into the complex interactions occurring in concentrated mesenchymal cell suspensions when combined with synthetic biomacromolecules commonly used as precursors in tissue engineering hydrogels, highlighting their substantial impacts on the resultant rheological footprint.

Effects of cell density and biomacromolecule addition on the flow behavior of concentrated mesenchymal cell suspensions.

With the rapidly growing interest in the use of mesenchymal stromal cells (MSCs) for cell therapy and regenerative medicine applications, either alone as an injected suspension, or dispersed within injectable hydrogel delivery systems, greater understanding of the structure-function-property characteristics of suspensions of adhesion-dependent mesenchymal cells is required. In this paper, we present the results of an experimental study into the flow behavior of concentrated suspensions of living cells of mesenchymal origin (fibroblasts) over a wide range of cell concentrations, with and without the addition of hyaluronic acid (HA), a commonly utilized biomolecule in injectable hydrogel formulations. We characterize the change in the shear viscosity as a function of shear stress and shear rate for cell volume fractions varying from 20 to 60%. We show that high volume fraction suspensions of living mesenchymal cells, known to be capable of homotypic interactions, exhibit highly complex but reproducible rheological footprints, including yield stress, shear thinning and shear-induced fracture behaviors. We show that with the addition of HA, we can significantly modify and tailor the rheology of these cell suspensions at all volume fractions. Using FACS and confocal imaging, we show that the observed effect of HA addition is due to a significantly modulation in the formation of cellular aggregates in these suspensions, and thus the resultant volume spanning network. Considering the aggregates as fractal structures, we show that by taking into account the changes in volume fractions with shear, we are able to plot a master curve for the range of conditions investigated and extract from it the average adhesion force between individual cells, across a population of millions of cells. The outcomes of this study not only provide new insight into the complexity of the flow behaviors of concentrated, adhesive mesenchymal cell suspensions, and their sensitivity to associative biomacromolecule addition, but also a novel, rapid method by which to measure the average adhesion force between individual cells, and the impacts of biomacromolecules on this important parameter.

Modeling Neurodegenerative Diseases Using In Vitro Compartmentalized Microfluidic Devices.

The human brain is a complex organ composed of many different types of cells interconnected to create an organized system able to efficiently process information. Dysregulation of this delicately balanced system can lead to the development of neurological disorders, such as neurodegenerative diseases (NDD). To investigate the functionality of human brain physiology and pathophysiology, the scientific community has been generated various research models, from genetically modified animals to two- and three-dimensional cell culture for several decades. These models have, however, certain limitations that impede the precise study of pathophysiological features of neurodegeneration, thus hindering therapeutical research and drug development. Compartmentalized microfluidic devices provide in vitro minimalistic environments to accurately reproduce neural circuits allowing the characterization of the human central nervous system. Brain-on-chip (BoC) is allowing our capability to improve neurodegeneration models on the molecular and cellular mechanism aspects behind the progression of these troubles. This review aims to summarize and discuss the latest advancements of microfluidic models for the investigations of common neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.